drugset / Trial / NCT01773083
Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Phase 3
Terminated
13 enrolled
Academic Medical Center - University of Amsterdam
Dutch Burns Foundation · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this international multi-center double-blind randomized placebo-controlled trial is to determine the effect of nebulized heparin, compared to placebo, on the number of ventilator-free days at day 28, in burn patients with confirmed inhalation trauma requiring mechanical ventilation.
Timeline
- Start
- 2013-10
- Primary completion
- 2016-10
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Heparin | Other / unclassified | 25000 iu | Other |